{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:18:48Z","timestamp":1794565128167,"version":"4.9.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"a high-level innovative talent program in Guizhou","award":["No. fzc 120171001"],"award-info":[{"award-number":["No. fzc 120171001"]}]},{"name":"a special fund for academic seedlings training and innovation at Zunyi Medical College","award":["Qian Kehe Pingtai Rencai No. (2017) 5733-034"],"award-info":[{"award-number":["Qian Kehe Pingtai Rencai No. (2017) 5733-034"]}]},{"name":"a special fund for science and technology research into traditional Chinese and national medicine in Guizhou","award":["No QZYY 2017-084"],"award-info":[{"award-number":["No QZYY 2017-084"]}]},{"name":"Guizhou Provincial Science and Technology Program","award":["[Qian Kehe Zhicheng(2025), Yiban 056]"],"award-info":[{"award-number":["[Qian Kehe Zhicheng(2025), Yiban 056]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14541-x","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:52:54Z","timestamp":1751953974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimal intrapleural therapy with alpha-hemolytic streptococci bio-product (Mannatide) in controlling malignant pleural effusion: a clustered systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Chun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Yang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"10","key":"14541_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/17476348.2020.1793672","volume":"14","author":"R Banka","year":"2020","unstructured":"Banka R, George V, Rahman NM. Multidisciplinary approaches to the management of malignant pleural effusions: a guide for the clinician. Expert Rev Respir Med. 2020;14(10):1009\u201318.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"14541_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1055\/s-0039-1698285","volume":"40","author":"R Thomas","year":"2019","unstructured":"Thomas R, Roy B, Maldonado F, Lee YCG. Management of Malignant Pleural Effusions-What Is New. Semin Respir Crit Care Med. 2019;40(3):323\u201339.","journal-title":"Semin Respir Crit Care Med"},{"issue":"18","key":"14541_CR3","first-page":"1691","volume":"22","author":"L-H Zhang","year":"2011","unstructured":"Zhang L-H, Guo Y-F, Sheng Y-C, Xie W, Ji R, Mei Q-B. Systematic review of platinum antitumor drugs combined with Mannatide in the treatment of malignant pleural effusion. China Pharm. 2011;22(18):1691\u20135.","journal-title":"China Pharm"},{"issue":"12","key":"14541_CR4","first-page":"1848","volume":"26","author":"J Zhu","year":"2011","unstructured":"Zhu J, Yu W-T. Systematic review of Mannatide plus Cisplatin treating malignant pleural effusion. West China Med J. 2011;26(12):1848\u201352.","journal-title":"West China Med J"},{"issue":"10","key":"14541_CR5","first-page":"585","volume":"22","author":"D Lin","year":"2012","unstructured":"Lin D. Literature analysis of Mannan peptide combined with platinum drugs in the treatment of malignant pleural effusion. Pharm Today. 2012;22(10):585\u20137+591.","journal-title":"Pharm Today"},{"issue":"5","key":"14541_CR6","first-page":"755","volume":"34","author":"B Chen","year":"2013","unstructured":"Chen B, Xu X-M, Yu T-T, Yang J. Meta analysis of Lifein combined with Cisplatin in chest catheterization perfusion chemotheapy for malignant pleural effusion. Med J of Wuhan Univ. 2013;34(5):755\u201361.","journal-title":"Med J of Wuhan Univ"},{"issue":"7","key":"14541_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","volume":"198","author":"DJ Feller-Kopman","year":"2018","unstructured":"Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, Iyer NP, Lee YCG, Lewis SZ, Maskell NA, et al. Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839\u201349.","journal-title":"Am J Respir Crit Care Med"},{"key":"14541_CR8","doi-asserted-by":"publisher","first-page":"108688","DOI":"10.1016\/j.intimp.2022.108688","volume":"107","author":"CQ Wang","year":"2022","unstructured":"Wang CQ, Shen YS, Chen XF, Jiang H, Yang XM, Fan TY, Li SG, Yang P, Zhan L, Chen R, et al. The intrapleural administration with thymic peptides in malignant pleural effusion: a clustered systematicreview and meta-analysis. Int Immunopharmacol. 2022;107:108688.","journal-title":"Int Immunopharmacol"},{"key":"14541_CR9","doi-asserted-by":"publisher","first-page":"816973","DOI":"10.3389\/fmed.2022.816973","volume":"9","author":"H Jiang","year":"2022","unstructured":"Jiang H, Yang XM, Wang CQ, Xu J, Huang J, Feng JH, Chen XF, Chen K, Zhan L, Xiao X, et al. Intrapleural Perfusion With Staphylococcal Enterotoxin C for Malignant Pleural Effusion: A Clustered Systematic Review and Meta-Analysis. Front Med (Lausanne). 2022;9:816973.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"14541_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1183\/09031936.04.00137403","volume":"24","author":"K Kishi","year":"2004","unstructured":"Kishi K, Homma S, Sakamoto S, Kawabata M, Tsuboi E, Nakata K, Yoshimura K. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Eur Respir J. 2004;24(2):263\u20136.","journal-title":"Eur Respir J"},{"issue":"3","key":"14541_CR11","first-page":"674","volume":"69","author":"KT Luh","year":"1992","unstructured":"Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial Cancer. 1992;69(3):674\u20139.","journal-title":"A randomized trial Cancer"},{"issue":"2","key":"14541_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.apsusc.2008.06.092","volume":"255","author":"JH Bi","year":"2008","unstructured":"Bi JH, Zhao JL, Bao L, Liu Y, Wu CS. Preparation and anti-tumor evaluation of polyactin A microparticles from supercritical CO2 processing. Appl Surf Sci. 2008;255(2):320\u20133.","journal-title":"Appl Surf Sci"},{"key":"14541_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.intimp.2017.10.020","volume":"54","author":"W Wang","year":"2018","unstructured":"Wang W, Li Y, Wang Y, Ren S, Li Y, Wang B. Polyactin A is a novel and potent immunological adjuvant for peptide-based cancer vaccine. Int Immunopharmacol. 2018;54:95\u2013102.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"14541_CR14","first-page":"556","volume":"76","author":"JL Thang","year":"2017","unstructured":"Thang JL, Xu C, Wan YL, Gao MX. Production of Mannatide by alpha-hemolytic Streptococcus Using Batch Fermentation with pH-shift Control. J Sci Ind Res. 2017;76(9):556\u201361.","journal-title":"J Sci Ind Res"},{"key":"14541_CR15","first-page":"673","volume":"11","author":"S Sun","year":"1985","unstructured":"Sun S. Polyactin A passed technical identification. Chin Pharm J. 1985;11:673\u2013673.","journal-title":"Chin Pharm J"},{"issue":"1","key":"14541_CR16","first-page":"35","volume":"32","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Xia W, Ji R, Guo Y, Sheng Y, Mei Q. Systematic review of mannatide injection plus platinum in the treatment of malignant solid tumor. Chin J Hos Pharm. 2012;32(1):35\u201340.","journal-title":"Chin J Hos Pharm"},{"issue":"24","key":"14541_CR17","first-page":"2917","volume":"21","author":"ZH Zhang","year":"2012","unstructured":"Zhang ZH, Hong JC, Chen ZJ, Mei QB. Systematic review of mannatide injection in the treatment of non-small cell lung cancer. Chin J New Drugs. 2012;21(24):2917\u201323.","journal-title":"Chin J New Drugs"},{"issue":"24","key":"14541_CR18","first-page":"2409","volume":"20","author":"ZH Zhang","year":"2011","unstructured":"Zhang ZH, Ji R, Guo YF, Sheng YC, Huo ZJ, Mei QB. Systematic review of mannatide injection in the treatment of lymphohaemopoietic tumors. Chin J New Drugs. 2011;20(24):2409\u201314.","journal-title":"Chin J New Drugs"},{"issue":"5","key":"14541_CR19","first-page":"409","volume":"12","author":"Z Fu","year":"2012","unstructured":"Fu Z, Feng J. Meta-analysis of mannatide injection as supportive therapy for lymphohaemopoietic tumor. Eval Anal Drug-Use Hosp China. 2012;12(5):409\u201313.","journal-title":"Eval Anal Drug-Use Hosp China"},{"issue":"6","key":"14541_CR20","first-page":"759","volume":"14","author":"QL Su","year":"2014","unstructured":"Su QL, Liu F, Wang DN, Yuan B, Luo FM. Clinical efficacy of mannatide for recurrent respiratory tract infection and its influence on immune function: A systematic review. Chin J Evid-Based Med. 2014;14(6):759\u201364.","journal-title":"Chin J Evid-Based Med"},{"issue":"18","key":"14541_CR21","first-page":"3071","volume":"18","author":"Y Liu","year":"2012","unstructured":"Liu Y, Huang J, Lu Y, Shu Y, Bian C, Fang J, Hu T. Systematic review of mannatide as adjuvant therapy for condyloma acuminatum. Med Recapitulate. 2012;18(18):3071\u20134.","journal-title":"Med Recapitulate"},{"issue":"03","key":"14541_CR22","first-page":"106","volume":"24","author":"Y Hao","year":"2015","unstructured":"Hao Y. The efficacy of different drugs in the treatment of lung with pleural effusion by intrapleural injection. Henan Med Res. 2015;24(03):106\u20137.","journal-title":"Henan Med Res"},{"issue":"35","key":"14541_CR23","first-page":"278","volume":"29","author":"Y Qi","year":"2019","unstructured":"Qi Y. The value of Mannatide and cisplatin in the treatment of lung cancer pleural effusion. China Health Care & Nutr. 2019;29(35):278.","journal-title":"China Health Care & Nutr"},{"issue":"4","key":"14541_CR24","first-page":"151","volume":"10","author":"W Zhao","year":"2020","unstructured":"Zhao W. Observation on the therapeutic effect of Mannatide combined with PC regimen in the treatment of malignant pleural effusion in lung adenocarcinoma. Yiyao Qianyan. 2020;10(4):151\u20132.","journal-title":"Yiyao Qianyan"},{"key":"14541_CR25","doi-asserted-by":"publisher","first-page":"154847","DOI":"10.1016\/j.phymed.2023.154847","volume":"115","author":"CQ Wang","year":"2023","unstructured":"Wang CQ, Xu J, Jiang H, Zheng XT, Zhang Y, Huang XR, She F, Fan TY, Zhan L, Feng JH, et al. The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: a clustered systematic review and meta-analysis. Phytomedicine. 2023;115:154847.","journal-title":"Phytomedicine"},{"key":"14541_CR26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"12","key":"14541_CR27","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/(SICI)1097-0142(19961215)78:12<2498::AID-CNCR8>3.0.CO;2-G","volume":"78","author":"A Emad","year":"1996","unstructured":"Emad A, Rezaian GR. Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline. A comparison of bleomycin or tetracycline alone versus a combination of bleomycin and tetracycline. Cancer. 1996;78(12):2498\u2013501.","journal-title":"Cancer"},{"issue":"4","key":"14541_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/1097-0142(19830215)51:4<752::AID-CNCR2820510434>3.0.CO;2-7","volume":"51","author":"AJ Zaloznik","year":"1983","unstructured":"Zaloznik AJ, Oswald SG, Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer. 1983;51(4):752\u20135.","journal-title":"Cancer"},{"key":"14541_CR29","doi-asserted-by":"publisher","first-page":"175346661881662","DOI":"10.1177\/1753466618816625","volume":"12","author":"W Keeratichananont","year":"2018","unstructured":"Keeratichananont W, Kaewdech A, Keeratichananont S. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial. Ther Adv Respir Dis. 2018;12:1753466618816625.","journal-title":"Ther Adv Respir Dis"},{"key":"14541_CR30","doi-asserted-by":"publisher","first-page":"649999","DOI":"10.3389\/fonc.2021.649999","volume":"11","author":"CQ Wang","year":"2021","unstructured":"Wang CQ, Huang XR, He M, Zheng XT, Jiang H, Chen Q, Fan TY, Zhan L, Ling J, Feng JH, et al. Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis. Front Oncol. 2021;11:649999.","journal-title":"Front Oncol"},{"key":"14541_CR31","doi-asserted-by":"publisher","first-page":"153260","DOI":"10.1016\/j.phymed.2020.153260","volume":"76","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Jiang Y, Chen XF, Wang CQ, Zheng XT, Xu WH, Zou XX, Zhou JM, Yang YH, Hu SS, et al. Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trials. Phytomedicine. 2020;76: 153260.","journal-title":"Phytomedicine"},{"issue":"8","key":"14541_CR32","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q","volume":"45","author":"JW Yates","year":"1980","unstructured":"Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;45(8):2220\u20134.","journal-title":"Cancer"},{"issue":"4","key":"14541_CR33","first-page":"220","volume":"27","author":"JK Clancey","year":"1995","unstructured":"Clancey JK. Karnofsky performance scale. J Neurosci Nurs. 1995;27(4):220.","journal-title":"J Neurosci Nurs"},{"issue":"1","key":"14541_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207\u201314.","journal-title":"Cancer"},{"issue":"3","key":"14541_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176\u201381.","journal-title":"Semin Radiat Oncol"},{"key":"14541_CR36","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M LT, Page MJ, (editors) WV: Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane 2021, Available from www.training.cochrane.org\/handbook."},{"key":"14541_CR37","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"14541_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12:9.","journal-title":"BMC Med Res Methodol"},{"key":"14541_CR39","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","volume":"340","author":"X Sun","year":"2010","unstructured":"Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:c117.","journal-title":"BMJ"},{"key":"14541_CR40","doi-asserted-by":"publisher","first-page":"104637","DOI":"10.1016\/j.phrs.2020.104637","volume":"153","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Jiang Y, Wang CQ, Hu SS, Huang XR, Chen XF, Huang J, Shan LJ, Tang YH, Wang YH, et al. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: a systematic review and meta-analysis of 54 randomized controlled trials. Pharmacol Res. 2020;153:104637.","journal-title":"Pharmacol Res"},{"issue":"1","key":"14541_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64\u201375.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"14541_CR42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","volume":"38","author":"K Thorlund","year":"2009","unstructured":"Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, Gluud LL, Als-Nielsen B, Gluud C. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009;38(1):276\u201386.","journal-title":"Int J Epidemiol"},{"key":"14541_CR43","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C: User manual for trial sequential analysis (TSA). Copenhagen: Copenhagen Trial Unit, Centre for Clinical Intervention Research 2016:.Rigshospitalet."},{"key":"14541_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:86.","journal-title":"BMC Med Res Methodol"},{"issue":"7650","key":"14541_CR45","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"12","key":"14541_CR46","first-page":"933","volume":"27","author":"P Ding","year":"2000","unstructured":"Ding P. Clinical observation on the treatment of malignant pleural effusion by local thoracic perfusion with Lierfan. Chin J Clin Oncol. 2000;27(12):933\u20134.","journal-title":"Chin J Clin Oncol"},{"issue":"11","key":"14541_CR47","first-page":"888","volume":"4","author":"S Deng","year":"2001","unstructured":"Deng S, Hu X, Yang D. Clinical efficacy of Mannatide with cisplatin for malignant pleural effusion though transcatheter pleural perfusion. Chin J Coal Ind Med. 2001;4(11):888\u2013888.","journal-title":"Chin J Coal Ind Med"},{"issue":"4","key":"14541_CR48","first-page":"47","volume":"1","author":"S Dai","year":"2002","unstructured":"Dai S, Ji X. Clinical observation on the treatment of malignant pleural effusion by continuous drainage of central venous catheter followed by injection of li\u2019erfan and cisplatin. Chin Res J Pract Med. 2002;1(4):47\u201347.","journal-title":"Chin Res J Pract Med"},{"issue":"8","key":"14541_CR49","first-page":"732","volume":"4","author":"D Zhao","year":"2002","unstructured":"Zhao D, Zhang C, Gao H. Clinical efficacy of Mannatide with cisplatin for malignant pleural effusion: a clinical study of 55 cases. Chin Pract New Med. 2002;4(8):732\u2013732.","journal-title":"Chin Pract New Med"},{"issue":"6","key":"14541_CR50","first-page":"70","volume":"17","author":"P Zhao","year":"2002","unstructured":"Zhao P, Jiang J. Clinical observance on curing malignant pleural effusion by Lifein combinations. J Jingchu Univ Technol. 2002;17(6):70\u20132.","journal-title":"J Jingchu Univ Technol"},{"issue":"4","key":"14541_CR51","first-page":"546","volume":"16","author":"Y An","year":"2003","unstructured":"An Y, Liu X, Fu G. Clinical observation on treating carcinous thorax dropsy by cisplatin and Lifein Chin J Pract Chin Modem Med. 2003;16(4):546\u2013546.","journal-title":"Clinical observation on treating carcinous thorax dropsy by cisplatin and Lifein Chin J Pract Chin Modem Med"},{"issue":"04","key":"14541_CR52","first-page":"336","volume":"1","author":"C Guo","year":"2003","unstructured":"Guo C, Li G, Wen S, Ren D. Comparison of three drugs in the treatment of lung cancer pleural effusion. Med J West China. 2003;1(04):336\u20137.","journal-title":"Med J West China"},{"issue":"9","key":"14541_CR53","first-page":"792","volume":"9","author":"H Liu","year":"2003","unstructured":"Liu H. Clinical study of carboplatin in combined with Lifein for malignant pleural effusions. Hebei Med. 2003;9(9):792\u20133.","journal-title":"Hebei Med"},{"issue":"3","key":"14541_CR54","first-page":"193","volume":"16","author":"J Sun","year":"2003","unstructured":"Sun J, Sheng Z, He M. Curative effect of Lifein plus cisplatin in treatment of malignant pleural effusion. J Basic Clin Oncol. 2003;16(3):193\u20134.","journal-title":"J Basic Clin Oncol"},{"issue":"7","key":"14541_CR55","first-page":"44","volume":"23","author":"Z Zhang","year":"2003","unstructured":"Zhang Z. Lifein combined with cisplatin for malignant pleural effusion: a clinical study of 30 cases. Clin Med. 2003;23(7):44\u201344.","journal-title":"Clin Med"},{"issue":"19","key":"14541_CR56","first-page":"37","volume":"44","author":"Y Chen","year":"2004","unstructured":"Chen Y, Shang Y, Li G. Clinical study of Lifein and cisplatin in the treatment of malignant pleural effusion. Shandong Med J. 2004;44(19):37\u20138.","journal-title":"Shandong Med J"},{"issue":"9","key":"14541_CR57","first-page":"25","volume":"2","author":"X Li","year":"2004","unstructured":"Li X, Wang H. Clinical study of li\u2019erfan combined with cisplatin in the treatment of malignant pleural effusion. Chin J TWM. 2004;2(9):25\u201325.","journal-title":"Chin J TWM"},{"issue":"11","key":"14541_CR58","first-page":"20","volume":"4","author":"H Liao","year":"2004","unstructured":"Liao H, Li M, Deng W. Clinical study of Lifein and cisplatin for malignant pleural effusion through pleural perfusion. China Med Bull. 2004;4(11):20\u20132.","journal-title":"China Med Bull"},{"issue":"3","key":"14541_CR59","first-page":"109","volume":"3","author":"T Xiao","year":"2004","unstructured":"Xiao T, Chen H. Clinical study of Mannatide and cisplatin for malignant pleural effusion through pleural perfusion. China New Med. 2004;3(3):109\u201310.","journal-title":"China New Med"},{"issue":"1","key":"14541_CR60","first-page":"37","volume":"17","author":"D Zhang","year":"2004","unstructured":"Zhang D, Liu T. Clinical study of Mannatide and cisplatin for malignant pleural effusion. J Cancer Contr Treat. 2004;17(1):37\u20138.","journal-title":"J Cancer Contr Treat"},{"issue":"2","key":"14541_CR61","first-page":"146","volume":"11","author":"X Zhao","year":"2004","unstructured":"Zhao X, Yu S, Li G, Yue J, Yu J. Clinical observation on efficacy of intrapleural injection of Lifein and cisplatin on malignant pleural effusions. Chin J Clin Oncol Rehab. 2004;11(2):146\u20138.","journal-title":"Chin J Clin Oncol Rehab"},{"issue":"6","key":"14541_CR62","first-page":"534","volume":"19","author":"D Zhu","year":"2004","unstructured":"Zhu D. Clinical observation on \u03b1-Mannatide and DDP in the treatment of malignant pleural effusion Med J Qilu. 2004;19(6):534\u2013534.","journal-title":"Clinical observation on \u03b1-Mannatide and DDP in the treatment of malignant pleural effusion Med J Qilu"},{"issue":"24","key":"14541_CR63","first-page":"3227","volume":"14","author":"Y Li","year":"2005","unstructured":"Li Y, Shi Y, Liu R, Zhou L. Clinical study of Mannatide for malignant pleural effusion through pleural perfusion. Mod J ITCWM. 2005;14(24):3227\u20138.","journal-title":"Mod J ITCWM"},{"issue":"19","key":"14541_CR64","first-page":"64","volume":"20","author":"X Liang","year":"2005","unstructured":"Liang X, He W, Li C. Effects of Lifein in the treatment of pleural effusion caused by pulmonary carcinoma. J Nursing Sci. 2005;20(19):64\u20135.","journal-title":"J Nursing Sci"},{"issue":"10","key":"14541_CR65","first-page":"954","volume":"3","author":"J Zhang","year":"2005","unstructured":"Zhang J. Clinical study of Lifein and cisplatin in the treatment of malignant pleural effusion. Chin J Currt Clin Med. 2005;3(10):954\u20135.","journal-title":"Chin J Currt Clin Med"},{"issue":"1","key":"14541_CR66","first-page":"53","volume":"34","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Zhang C, Zhang M. Clinical efficacy of biological response modifier and cisplatin for malignant pleural effusion through pleural perfusion. J Med Res. 2005;34(1):53\u20134.","journal-title":"J Med Res"},{"issue":"24","key":"14541_CR67","first-page":"2600","volume":"3","author":"L Zheng","year":"2005","unstructured":"Zheng L, Liu J, Qi X. Clinical observation of Lierfan plus carboplatin in the treatment of malignant pleural effusion. Chin J Modern Clin Med. 2005;3(24):2600.","journal-title":"Chin J Modern Clin Med"},{"issue":"1","key":"14541_CR68","first-page":"37","volume":"37","author":"H Mao","year":"2006","unstructured":"Mao H, Guan M. Clinical study of Lifein for malignant pleural effusion. Guangzhou Med J. 2006;37(1):37\u20138.","journal-title":"Guangzhou Med J"},{"issue":"1","key":"14541_CR69","first-page":"102","volume":"22","author":"F Yang","year":"2006","unstructured":"Yang F, Liu K, Wen Z, Tang H. Clinical study of Lifein and carboplatin for malignant pleural effusion through pleural perfusion. J Guangdong Pharm Univ. 2006;22(1):102-102,106.","journal-title":"J Guangdong Pharm Univ"},{"issue":"04","key":"14541_CR70","first-page":"335","volume":"19","author":"J Yang","year":"2006","unstructured":"Yang J, Guo M, Li X. Clinical observation of Lierfan in the treatment of malignant pleural effusion. J Basic Clin Oncol. 2006;19(04):335\u2013335.","journal-title":"J Basic Clin Oncol"},{"issue":"04","key":"14541_CR71","first-page":"373","volume":"24","author":"H Zhang","year":"2006","unstructured":"Zhang H, Da C, Wu Y, Li Q, Chu Y, Du S. Clinical observation of Lierfan in the treatment of malignant pleural effusion: a study of 21 cases. China Medl Abstracts Intern Med. 2006;24(04):373\u20134.","journal-title":"China Medl Abstracts Intern Med"},{"issue":"05","key":"14541_CR72","first-page":"437","volume":"17","author":"Z Liu","year":"2008","unstructured":"Liu Z, Wang M, Qi J, Zhang X, Wu N. Clinical comparative analysis of cisplatin combined with Mannatide and with OK-432 in intrapleural therapy for malignant pleural effusion. China Cancer. 2008;17(05):437\u20139.","journal-title":"China Cancer"},{"issue":"4","key":"14541_CR73","first-page":"51","volume":"5","author":"W Zhang","year":"2008","unstructured":"Zhang W. Clinical study of Lifein and DDP for malignant pleural effusion through pleural perfusion. China Med Her. 2008;5(4):51\u201351.","journal-title":"China Med Her"},{"issue":"3","key":"14541_CR74","first-page":"255","volume":"1","author":"F Fu","year":"2009","unstructured":"Fu F, Li Y, Liu J, Han W, Feng X. Clinical study of Mannatide and DDP for malignant pleural effusion through pleural perfusion. Chin J Oncol Prev Treat. 2009;1(3):255\u20136.","journal-title":"Chin J Oncol Prev Treat"},{"issue":"23","key":"14541_CR75","first-page":"719","volume":"13","author":"X Zhao","year":"2009","unstructured":"Zhao X, Wang W, Zhang J. Clinical study of Mannatide and carboplatin for malignant pleural effusion of lung cancer. Med Forum. 2009;13(23):719\u201320.","journal-title":"Med Forum"},{"issue":"11","key":"14541_CR76","first-page":"2167","volume":"18","author":"H Hu","year":"2010","unstructured":"Hu H, Teng G, Li L, Chi J, Ju Y, Yang Y. Clinical observation of close thoracic cavity drainage and perfusion of \u03b1-mannatide on treating malignant pleural effusion. J Modern Oncol. 2010;18(11):2167\u20139.","journal-title":"J Modern Oncol"},{"issue":"08","key":"14541_CR77","first-page":"752","volume":"11","author":"Z Huang","year":"2010","unstructured":"Huang Z. Curative effect of Mannatide combined with cisplatin on pleural effusion of lung cancer. Sci & Tech Inform. 2010;11(08):752\u2013752.","journal-title":"Sci & Tech Inform"},{"issue":"16","key":"14541_CR78","first-page":"190","volume":"5","author":"Y Ma","year":"2010","unstructured":"Ma Y. Lifein combined with carboplatin for malignant pleural effusion: A clinical study of 32 cases. China Prac Med. 2010;5(16):190\u20131.","journal-title":"China Prac Med"},{"issue":"26","key":"14541_CR79","first-page":"59","volume":"7","author":"X Wu","year":"2010","unstructured":"Wu X. Efficacy observation of thoracic cavity perfusion with carboplatin and Manna peptide in the treatment of malignant pleural effusion in patients with lung cancer. China Med Her. 2010;7(26):59\u201360.","journal-title":"China Med Her"},{"issue":"7","key":"14541_CR80","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s12032-009-9384-8","volume":"18","author":"W Yang","year":"2010","unstructured":"Yang W, Ding F, Li X. Clinical efficacy of Mannatide and cisplatin for malignant pleural effusion. J Mod Oncol. 2010;18(7):1329\u201331.","journal-title":"J Mod Oncol"},{"issue":"7","key":"14541_CR81","first-page":"1030","volume":"15","author":"H Zhang","year":"2010","unstructured":"Zhang H, Jia M. Observation on the treatment of lung cancer pleural effusion with intrapleural injection of hydroxycamptothecin and other drugs. J Clin Pulm Med. 2010;15(7):1030\u20131030.","journal-title":"J Clin Pulm Med"},{"issue":"19","key":"14541_CR82","first-page":"35","volume":"30","author":"X Ding","year":"2011","unstructured":"Ding X. Clinical study of Lifein and chemotherapy for malignant pleural effusion through pleural perfusion. Nei Mongol J TCM. 2011;30(19):35\u20136.","journal-title":"Nei Mongol J TCM"},{"issue":"12","key":"14541_CR83","first-page":"1250","volume":"40","author":"Y Gong","year":"2011","unstructured":"Gong Y. Clinical efficacy of Mannatide with cisplatin for malignant pleural effusion. Shanxi Med J. 2011;40(12):1250\u20131.","journal-title":"Shanxi Med J"},{"issue":"10","key":"14541_CR84","first-page":"1104","volume":"13","author":"W Luo","year":"2011","unstructured":"Luo W, Wu W, Hou L. Comparison of cisplatin combined with Endostar and Mannatide in the treatment of malignant pleural effusion. Zhejiang Clin Med J. 2011;13(10):1104\u20136.","journal-title":"Zhejiang Clin Med J"},{"issue":"11","key":"14541_CR85","first-page":"99","volume":"38","author":"S Ren","year":"2011","unstructured":"Ren S, Wei H, Li L. Clinical efficacy of Mannatide with cisplatin for malignant pleural effusion by pleural perfusion: A clinical study of 42 cases. Chin J Pract Med. 2011;38(11):99\u201399.","journal-title":"Chin J Pract Med"},{"issue":"32","key":"14541_CR86","first-page":"316","volume":"09","author":"X Wang","year":"2011","unstructured":"Wang X, Li F. Clinical study of Mannatide with cisplatin for malignant pleural effusion: A clinical study of 84 cases. Guide China Med. 2011;09(32):316\u20137.","journal-title":"Guide China Med"},{"issue":"10","key":"14541_CR87","first-page":"1565","volume":"16","author":"J Zhang","year":"2011","unstructured":"Zhang J, Sun H, Wang R. Observation of the efficacy of intra-pleural injection of Mannatide and carboplatin in treatment of malignant pleural effusion. J Clin Pulm Med. 2011;16(10):1565\u20136.","journal-title":"J Clin Pulm Med"},{"issue":"02","key":"14541_CR88","first-page":"59","volume":"18","author":"C Zhao","year":"2011","unstructured":"Zhao C. Clinical efficacy of Mannatide and chemotherapy for malignant pleural effusion. China Mod Med. 2011;18(02):59\u201362.","journal-title":"China Mod Med"},{"issue":"19","key":"14541_CR89","first-page":"90","volume":"18","author":"H Li","year":"2012","unstructured":"Li H, Xiao M. Mannatide with cisplatin for malignant pleural effusion via pleural perfusion: A clinical study of 45 cases. J Qilu Nurs. 2012;18(19):90\u201390.","journal-title":"J Qilu Nurs"},{"issue":"3","key":"14541_CR90","first-page":"326","volume":"15","author":"K Li","year":"2012","unstructured":"Li K, Yang Z, Li X. Clinical comparative analysis of thoracic close drainage with Mannatide intra cavitary administration in combination with cisplatin in the treatment of malignant pleural effusion. Chin J Coal Ind Med. 2012;15(3):326\u20138.","journal-title":"Chin J Coal Ind Med"},{"issue":"43","key":"14541_CR91","first-page":"78","volume":"52","author":"C Wang","year":"2012","unstructured":"Wang C, Zhang Y. Mannatide with cisplatin for malignant pleural effusion by pleural perfusion: A clinical study of 39 cases. Shandong Med J. 2012;52(43):78\u20139.","journal-title":"Shandong Med J"},{"issue":"23","key":"14541_CR92","first-page":"72","volume":"9","author":"J Zhong","year":"2012","unstructured":"Zhong J. Clinic effect of intrapleural infusion with Mannatide and carboplatin in treatment for malignant pleuritic fluid in patiens with lung cancer. World Health Digest. 2012;9(23):72\u20134.","journal-title":"World Health Digest"},{"issue":"8","key":"14541_CR93","first-page":"1224","volume":"35","author":"W Cheng","year":"2013","unstructured":"Cheng W, Han R. Clinical efficacy of Mannatide and cisplatin for malignant pleural effusion by pleural perfusion. Hebei Med J. 2013;35(8):1224\u20131224.","journal-title":"Hebei Med J"},{"issue":"4","key":"14541_CR94","first-page":"233","volume":"5","author":"M Feng","year":"2013","unstructured":"Feng M, Zhang Y, Na Z. Intraluminal injection of mannan peptide combined with urokinase for the treatment of malignant pleural effusion. China J Pharmaceutical Economics. 2013;5(4):233\u20134.","journal-title":"China J Pharmaceutical Economics"},{"issue":"06","key":"14541_CR95","first-page":"486","volume":"11","author":"M Li","year":"2013","unstructured":"Li M. Clinical efficacy of Mannan peptide with carboplatin for malignant pleural effusion in non-small cell lung cancer. Guide China Med. 2013;11(06):486\u20137.","journal-title":"Guide China Med"},{"issue":"2","key":"14541_CR96","first-page":"138","volume":"26","author":"G Ling","year":"2013","unstructured":"Ling G, Chen D, Xie Y. Effect of Mannatide combined with cisplatin on malignant pleural effusion. J Basic Clin Oncol. 2013;26(2):138\u20139.","journal-title":"J Basic Clin Oncol"},{"issue":"27","key":"14541_CR97","first-page":"124","volume":"51","author":"C Liu","year":"2013","unstructured":"Liu C. Mannatide cisplatin in the treatment of malignant pleural effusion observation. China Modern Doctor. 2013;51(27):124\u20135.","journal-title":"China Modern Doctor"},{"issue":"8","key":"14541_CR98","first-page":"1531","volume":"18","author":"Y Wang","year":"2013","unstructured":"Wang Y, Chen W, Xu L. Clinical study of oral administration of gefitinib and intrapleural injection of Mannatide in the treatment of advanced pleural metastatic lung adenocarcinoma. J Clin Pulm Med. 2013;18(8):1531\u201346.","journal-title":"J Clin Pulm Med"},{"issue":"8","key":"14541_CR99","first-page":"1841","volume":"22","author":"S Chen","year":"2014","unstructured":"Chen S, Huang J, Xiao W. Clinical observation of intrapleural injection of Mannatide and low - dose cisplatin in the treatment of malignant pleural effusion. J Modern Oncol. 2014;22(8):1841\u20133.","journal-title":"J Modern Oncol"},{"issue":"4","key":"14541_CR100","first-page":"315","volume":"31","author":"X Cheng","year":"2014","unstructured":"Cheng X, Liu J, Hao W. Mannatide with cisplatin for malignant pleural effusion by pleural perfusion: A clinical study of 36 cases. J Chengde Med Coll. 2014;31(4):315\u20136.","journal-title":"J Chengde Med Coll"},{"issue":"29","key":"14541_CR101","first-page":"16","volume":"52","author":"S He","year":"2014","unstructured":"He S, Liu H, Zhao Z, Li X. Therapeutic effect of Mannatide injection and nedaplatin on malignant pleural effusion. China Modern Doctor. 2014;52(29):16\u20138.","journal-title":"China Modern Doctor"},{"issue":"3","key":"14541_CR102","first-page":"256","volume":"12","author":"X Huang","year":"2014","unstructured":"Huang X, Song Z, Wu X. Clinical efficacy of combined application of oxaliplatin and mannan peptide in the treatment of malignant pleural effusion. Contemp Med Forum. 2014;12(3):256\u20137.","journal-title":"Contemp Med Forum"},{"issue":"08","key":"14541_CR103","first-page":"1235","volume":"16","author":"W Li","year":"2014","unstructured":"Li W. Clinical efficacy of Mannatide and cisplatin for malignant pleural effusion. Chin J Med Guide. 2014;16(08):1235\u20136.","journal-title":"Chin J Med Guide"},{"issue":"09","key":"14541_CR104","first-page":"1224","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang Y. Clinical effect of intrapleural perfusion of Mannatide in treatment of malignant pleural effusion. Chin J Med Guide. 2014;16(09):1224\u20135.","journal-title":"Chin J Med Guide"},{"issue":"08","key":"14541_CR105","first-page":"908","volume":"43","author":"Z Wei","year":"2014","unstructured":"Wei Z, Chen T, Xu X, Zhang W, Meng Y, Yang G, Tang L. Therapeutic effect of Mannan peptide combined with nedaplatin in the treatment of pleural effusion caused by lung cancer. Shanxi Med J. 2014;43(08):908\u201310.","journal-title":"Shanxi Med J"},{"issue":"12","key":"14541_CR106","first-page":"1488","volume":"16","author":"M Wu","year":"2014","unstructured":"Wu M, Chen X, Ming B, Liu S. Efficacy and safety of Mannatide combined with cisplatin in the treatment of malignant pleural effusion. Chin J Med Guide. 2014;16(12):1488\u201390.","journal-title":"Chin J Med Guide"},{"issue":"01","key":"14541_CR107","first-page":"114","volume":"22","author":"X Zhang","year":"2014","unstructured":"Zhang X. Mannatide with cisplatin for malignant pleural effusion: A clinical study of 47 cases. Chin J Trauma Disalbility Med. 2014;22(01):114\u20135.","journal-title":"Chin J Trauma Disalbility Med"},{"issue":"05","key":"14541_CR108","first-page":"554","volume":"7","author":"M Zhao","year":"2014","unstructured":"Zhao M. Mannatide in the treatment of malignant pleural effusion: A clinical study of 88 cases. Chin J Lung Dis. 2014;7(05):554\u20135.","journal-title":"Chin J Lung Dis."},{"issue":"34","key":"14541_CR109","first-page":"232","volume":"12","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Liang C, Xing D. The short-term efficacy of Mannan peptide combined with chemotherapeutic drug thoracic perfusion in the treatment of malignant pleural effusion. Guide China Med. 2014;12(34):232\u20133.","journal-title":"Guide China Med"},{"issue":"13","key":"14541_CR110","first-page":"138","volume":"9","author":"M Du","year":"2015","unstructured":"Du M. Treatment of 57 cases of lung cancer complicated with pleural effusion by intrapleural infusion of mannan peptide combined with nedaplatin. Chin J Mod Drug Appl. 2015;9(13):138\u201340.","journal-title":"Chin J Mod Drug Appl"},{"issue":"07","key":"14541_CR111","first-page":"102","volume":"9","author":"Z Song","year":"2015","unstructured":"Song Z. Efficacy of Mannan peptide and nedaplatin in the treatment of lung cancer with pleural effusion. Chin J Mod Drug Appl. 2015;9(07):102\u20133.","journal-title":"Chin J Mod Drug Appl"},{"issue":"23","key":"14541_CR112","first-page":"170","volume":"10","author":"F Wang","year":"2015","unstructured":"Wang F, Li Z, Wang S. Clinical observation on the treatment of malignant pleural effusion with indwelling central venous catheter and intrapleural infusion of nedaplatin. China Pract Med. 2015;10(23):170\u20132.","journal-title":"China Pract Med"},{"issue":"S1","key":"14541_CR113","first-page":"143","volume":"16","author":"Y Lian","year":"2016","unstructured":"Lian Y. Clinical observation of high dose glycan peptide pleural perfusion combined with hyperthermia in the treatment of malignant pleural effusion. Eval Anal Drug-Use Hosp China. 2016;16(S1):143\u2013143.","journal-title":"Eval Anal Drug-Use Hosp China"},{"issue":"09","key":"14541_CR114","first-page":"61","volume":"36","author":"F Liu","year":"2016","unstructured":"Liu F. Efficacy and safety of Mannan peptide and cisplatin in the treatment of malignant pleural effusion by intrathoracic perfusion. Clin Med. 2016;36(09):61\u20133.","journal-title":"Clin Med"},{"issue":"06","key":"14541_CR115","first-page":"1028","volume":"32","author":"Y Liu","year":"2016","unstructured":"Liu Y, Fang S, Qi H, Zhang Y, Liu B, Li Q. Clinical effect of Endostar combined with Mannatide in the treatment of malignant pleural effusion. J Pract Med. 2016;32(06):1028\u20139.","journal-title":"J Pract Med"},{"issue":"02","key":"14541_CR116","first-page":"302","volume":"22","author":"S Zhang","year":"2016","unstructured":"Zhang S. Clinical study of cisplatin and Mannan peptide in the treatment of malignant pleural effusion by intrathoracic perfusion. Hebei Med J. 2016;22(02):302\u20134.","journal-title":"Hebei Med J"},{"issue":"9","key":"14541_CR117","first-page":"1764","volume":"32","author":"G Lu","year":"2017","unstructured":"Lu G, Zhang Y, Hao K. Observation on the therapeutic effect of Mannatide combined with PC regimen in the treatment of malignant pleural effusion in lung adenocarcinoma. Drugs & Clinic. 2017;32(9):1764\u20137.","journal-title":"Drugs & Clinic"},{"issue":"68","key":"14541_CR118","first-page":"130","volume":"17","author":"C Ouyang","year":"2017","unstructured":"Ouyang C, Huang R, Wu Y. Clinical observation of cisplatin combined with Mannatide in the treatment of malignant pleural effusion. World Latest Med Inform. 2017;17(68):130\u20132.","journal-title":"World Latest Med Inform"},{"issue":"3","key":"14541_CR119","first-page":"11","volume":"28","author":"C Yao","year":"2018","unstructured":"Yao C. Study on the treatment of malignant pleural effusion with Chlorophenol-mannopeptide. J Shanxi Med Coll Contin Edu. 2018;28(3):11\u20133.","journal-title":"J Shanxi Med Coll Contin Edu"},{"issue":"3","key":"14541_CR120","first-page":"302","volume":"31","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li X. Effect of intrapleural infusion of endostatin combined with mannan peptide on MMP-9 and vascular endothelial growth factor in serum and pleural effusion of patients with non-small cell lung cancer and malignant pleural effusion. Hainan Med J. 2020;31(3):302\u20135.","journal-title":"Hainan Med J"},{"issue":"Suppl 1","key":"14541_CR121","first-page":"204","volume":"24","author":"XY Zeng","year":"1993","unstructured":"Zeng XY. Experimental research on immunological activity of Polyactin A. Southeast Asian J Trop Med Public Health. 1993;24(Suppl 1):204\u20135.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"2","key":"14541_CR122","first-page":"135","volume":"12","author":"QL Hu","year":"1991","unstructured":"Hu QL, Wang H, Wang YS, Shen WM, Chen RX, Wang P. Influences of a novel immunopotentiator polyactin A on interleukin 1 production and responsiveness in mice. Zhongguo Yao Li Xue Bao. 1991;12(2):135\u201340.","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"2","key":"14541_CR123","first-page":"365","volume":"20","author":"M Wang","year":"2015","unstructured":"Wang M. Clinical study of intrapleural injection with Sapylin in Malignant pleural effusion. J Clin Pulm Med. 2015;20(2):365-366,368.","journal-title":"J Clin Pulm Med"},{"issue":"13","key":"14541_CR124","first-page":"235","volume":"9","author":"H Tu","year":"2019","unstructured":"Tu H, Wu Y, Wu Q. Curative effect of sapilin and cisplatin in the control of malignant pleural effusion. China Med Pharm. 2019;9(13):235\u20137.","journal-title":"China Med Pharm"},{"issue":"1","key":"14541_CR125","first-page":"84","volume":"46","author":"Y-P Sun","year":"2017","unstructured":"Sun Y-P, Wang C-Q, Chen L, Li N-N, Yao X-S, Xiao Z. Effectiveness and safety of interleukin-2 plus cisplatin for treating malignant pleural effusion:a meta analysis. Chongqing Med. 2017;46(1):84-89,93.","journal-title":"Chongqing Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14541-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:04:04Z","timestamp":1751958244000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14541-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14541"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14541-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1155"}}